For the year ending 2025-12-31, MQ had $86,415K increase in cash & cash equivalents over the period. $160,788K in free cash flow.
| Cash Flow | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Net (loss) income | -13,925 | 27,287 | -222,962 | - |
| Gain on sale of equity method investment | - | 0 | 0 | 17,889 |
| Share-based compensation expense | 104,788 | 136,562 | 180,739 | 160,743 |
| Impairment of other financial instruments | - | 0 | 0 | 11,616 |
| Depreciation and amortization | 27,163 | 17,460 | 10,741 | - |
| Non-cash operating leases expense | 2,266 | 1,756 | 2,527 | 2,281 |
| Amortization of premium on short-term investments | 755 | 3,232 | 4,495 | -277 |
| Executive chairman long-term performance award | 0 | -144,617 | - | - |
| Non-cash postcombination compensation expense | 0 | 0 | 32,430 | - |
| Other | -558 | -1,669 | -736 | -649 |
| Accounts receivable | 8,864 | 11,202 | 4,556 | 2,577 |
| Settlements receivable | 1,834 | -13,719 | 11,894 | 6,762 |
| Network incentives receivable | -5,717 | 12,969 | 11,146 | 12,262 |
| Prepaid expenses and other assets | 2,092 | -462 | -7,900 | 8,621 |
| Accounts payable | -81 | -350 | -1,956 | 254 |
| Revenue share payable | 31,127 | 19,754 | 31,451 | 21,015 |
| Accrued expenses and other liabilities | 22,710 | 15,112 | 14,983 | 22,257 |
| Operating lease liabilities | -4,155 | -3,241 | -3,394 | -3,020 |
| Net cash provided by operating activities | 162,623 | 58,170 | 21,104 | -12,966 |
| Purchase of patents | - | 0 | 0 | 1,600 |
| Restricted cash acquired in business combination | -229,650 | - | - | - |
| Purchase of equity method investment and purchase option | - | - | 0 | 0 |
| Maturities of short-term investments | 120,885 | 92,000 | 501,534 | 77,400 |
| Cash paid for business acquisition, net of cash acquired | 45,663 | 0 | 135,777 | - |
| Capitalization of internal-use software | 28,425 | 18,794 | 11,889 | - |
| Purchases of short-term investments | 3,501 | 0 | 892,430 | 70,495 |
| Sale of equity method investment | - | 0 | 0 | 25,732 |
| Purchases of property and equipment | 1,835 | 2,418 | 762 | 2,319 |
| Sales of short-term investments | 0 | 0 | 577,934 | 0 |
| Realized loss on investments | 0 | 0 | 94 | - |
| Proceeds from issuance of redeemable convertible preferred stock, net of issuance costs | - | - | - | 0 |
| Payment of deferred offering costs | - | - | 0 | 0 |
| Net cash provided by investing activities | 271,111 | 70,788 | 38,516 | 28,718 |
| Proceeds from initial public offering, net of underwriters discounts and commissions | - | - | 0 | 0 |
| Repurchase of common stock | 391,366 | 154,425 | 190,420 | 78,136 |
| Taxes paid related to net share settlement of restricted stock units | 36,973 | 35,407 | 26,662 | 15,362 |
| Change in funds payable and amounts due to customers | 77,256 | - | - | - |
| Proceeds from exercise of warrants | - | - | 0 | 0 |
| Proceeds from shares issued in connection with employee stock purchase plan | 2,101 | 2,715 | 3,066 | 4,762 |
| Proceeds from exercise of stock options, including early exercised stock options, net of repurchase of early exercised unvested options | 1,663 | 203 | 5,289 | 9,249 |
| Payment of acquisition-related contingent consideration | 0 | 0 | 53,067 | - |
| Net cash used in financing activities | -347,319 | -186,914 | -261,794 | -79,487 |
| Increase (decrease) in cash, cash equivalents, and restricted cash | 86,415 | -57,956 | -202,174 | -63,735 |
| Cash, cash equivalents, and restricted cash - beginning of period | 931,516 | - | - | - |
| Cash, cash equivalents, and restricted cash - end of period | 1,017,931 | - | - | - |
Marqeta, Inc. (MQ)
Marqeta, Inc. (MQ)